Research conducted in Korean hospitals has shown that 14.4% of patients tested for ANA were positive, yet less than 1% of these cases resulted in diagnoses of ANA-associated rheumatic diseases, underscoring the need for cautious interpretation of ANA tests (9). The gene discussed is BTG3; the disease is rheumatic disorder.